Advertisement
Advertisement
AIM
AIM ImmunoTech Inc.
0.85
USDSponsored
-0.12
-12.21%
Mar 25, 15:58 UTC -4
Closed
After-Market
0.73
-0.12
-14.08%
AIM Earnings Reports
Positive Surprise Ratio
AIM beat 14 of 29 last estimates.
48%
Next Report
Next Week
Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.97
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
-100.00%
/-90.30%
AIM ImmunoTech Inc. earnings per share and revenue
On --, AIM reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Relmada Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.28
Surprise
-103.08%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
FAQ
What were AIM ImmunoTech Inc.'s earnings and revenue for the latest quarter Q-- --?
For Q-- --, AIM ImmunoTech Inc. reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to AIM ImmunoTech Inc.'s Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is AIM ImmunoTech Inc. expected to report next?
The next earning report is scheduled for Mar 30, 2026.
What are the forecasts for AIM ImmunoTech Inc.'s next earnings report?
Based on 3
analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement